1. Home
  2. CSIQ vs EVMN Comparison

CSIQ vs EVMN Comparison

Compare CSIQ & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canadian Solar Inc. (ON)

CSIQ

Canadian Solar Inc. (ON)

HOLD

Current Price

$18.61

Market Cap

824.4M

Sector

Technology

ML Signal

HOLD

EVMN

Evommune Inc.

N/A

Current Price

$22.72

Market Cap

825.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CSIQ
EVMN
Founded
2001
2020
Country
Canada
United States
Employees
N/A
48
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
824.4M
825.5M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
CSIQ
EVMN
Price
$18.61
$22.72
Analyst Decision
Hold
Strong Buy
Analyst Count
10
10
Target Price
$17.36
$43.88
AVG Volume (30 Days)
3.2M
381.8K
Earning Date
05-14-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.61
N/A
Revenue Next Year
$13.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.41
$13.89
52 Week High
$34.59
$33.20

Technical Indicators

Market Signals
Indicator
CSIQ
EVMN
Relative Strength Index (RSI) 56.18 46.84
Support Level $12.75 $21.32
Resistance Level $21.07 $23.08
Average True Range (ATR) 1.70 1.25
MACD 0.05 0.13
Stochastic Oscillator 57.15 51.43

Price Performance

Historical Comparison
CSIQ
EVMN

About CSIQ Canadian Solar Inc. (ON)

Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects.. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment focused on solar modules and battery energy storage manufacturing and products. Its Recurrent segment focused on utility-scale solar power and battery energy storage project development and operation. Key revenue is generated from CSI Solar segment.

About EVMN Evommune Inc.

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Share on Social Networks: